Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Dicerna Pharmaceuticals Inc (DRNA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dicerna Pharmaceuticals Inc since year 2005.
Table 2 shows the detailed insider transactions of Dicerna Pharmaceuticals Inc since 2005.
The reporting company's ticker symbol is DRNA. The reporting company's CIK number is 1399529.
The total value of stock buying since 2005 is $38,336,508.
The total value of stock sales since 2005 is $70,819,241.
The total value of stock option exercises since 2005 is $876,480.
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-05 | 0 | $0 | 1,600,000 | $20,000,000 | 0 | $0 |
| 2019-04 | 0 | $0 | 15,000 | $225,000 | 15,000 | $51,300 |
| 2018-11 | 0 | $0 | 524,575 | $7,048,379 | 0 | $0 |
| 2018-10 | 0 | $0 | 374,725 | $5,193,072 | 0 | $0 |
| 2018-09 | 0 | $0 | 2,301 | $40,267 | 2,301 | $7,869 |
| 2018-08 | 0 | $0 | 38,341 | $613,456 | 14,680 | $50,205 |
| 2018-06 | 0 | $0 | 0 | $0 | 21,197 | $148,379 |
| 2018-05 | 0 | $0 | 19,669 | $295,035 | 10,000 | $34,200 |
| 2018-04 | 0 | $0 | 8,965 | $116,545 | 0 | $0 |
| 2018-03 | 0 | $0 | 1,035 | $13,455 | 0 | $0 |
| 2018-01 | 0 | $0 | 0 | $0 | 360 | $1,231 |
| 2017-12 | 285,000 | $1,995,000 | 0 | $0 | 13,745,272 | $0 |
| 2016-11 | 33,100 | $122,643 | 23,766 | $83,656 | 0 | $0 |
| 2016-05 | 5,000 | $16,365 | 0 | $0 | 0 | $0 |
| 2016-02 | 0 | $0 | 0 | $0 | 34,722 | $118,749 |
| 2015-02 | 0 | $0 | 37,532 | $976,582 | 0 | $0 |
| 2014-12 | 0 | $0 | 0 | $0 | 2,500 | $8,550 |
| 2014-11 | 0 | $0 | 536,129 | $5,627,405 | 0 | $0 |
| 2014-10 | 0 | $0 | 117,778 | $1,277,613 | 0 | $0 |
| 2014-03 | 0 | $0 | 786,138 | $29,308,776 | 0 | $0 |
| 2014-02 | 2,400,000 | $36,000,000 | 0 | $0 | 0 | $0 |
| 2014-01 | 13,500 | $202,500 | 0 | $0 | 123,794 | $421,343 |
| 2013-11 | 0 | $0 | 0 | $0 | 10,133 | $34,654 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-29 | Koppel Adam (Director) | Sale | 1,600,000 | 12.50 | 20,000,000 |
| 2019-04-02 | Weissman James B (Chief Business Officer) | Sale | 15,000 | 15.00 | 225,000 |
| 2019-04-02 | Weissman James B (Chief Business Officer) | Option Ex | 15,000 | 3.42 | 51,300 |
| 2018-11-06 | Halak Brian K (Director) | Sale | 104,328 | 13.67 | 1,426,163 |
| 2018-11-05 | Halak Brian K (Director) | Sale | 39,901 | 12.98 | 517,914 |
| 2018-11-02 | Halak Brian K (Director) | Sale | 190,771 | 13.47 | 2,569,685 |
| 2018-11-01 | Halak Brian K (Director) | Sale | 189,575 | 13.37 | 2,534,617 |
| 2018-10-31 | Halak Brian K (Director) | Sale | 129,629 | 13.60 | 1,762,954 |
| 2018-10-30 | Halak Brian K (Director) | Sale | 245,096 | 13.99 | 3,430,118 |
| 2018-09-05 | Weissman James B (Chief Business Officer) | Sale | 2,301 | 17.50 | 40,267 |
| 2018-09-05 | Weissman James B (Chief Business Officer) | Option Ex | 2,301 | 3.42 | 7,869 |
| 2018-08-17 | Weissman James B (Chief Business Officer) | Option Ex | 14,680 | 3.42 | 50,205 |
| 2018-08-15 | Langer Dennis | Sale | 38,341 | 16.00 | 613,456 |
| 2018-06-07 | Halak Brian K (Director) | Option Ex | 21,197 | 7.00 | 148,379 |
| 2018-05-09 | Weissman James B (Chief Business Officer) | Sale | 10,000 | 15.00 | 150,000 |
| 2018-05-09 | Weissman James B (Chief Business Officer) | Option Ex | 10,000 | 3.42 | 34,200 |
| 2018-05-09 | Brown Bob D (Chief Scientific Officer) | Sale | 9,669 | 15.00 | 145,035 |
| 2018-04-20 | Weissman James B (Chief Business Officer) | Sale | 8,965 | 13.00 | 116,545 |
| 2018-03-19 | Weissman James B (Chief Business Officer) | Sale | 1,035 | 13.00 | 13,455 |
| 2018-01-26 | Langer Dennis (Director) | Option Ex | 360 | 3.42 | 1,231 |
| 2017-12-18 | Koppel Adam (Director) | Buy | 285,000 | 7.00 | 1,995,000 |
| 2017-12-18 | Koppel Adam (Director) | Option Ex | 8,454,388 | .00 | 0 |
| 2017-12-18 | Kolchinsky Peter | Option Ex | 2,645,442 | .00 | 0 |
| 2017-12-18 | Ra Capital Healthcare Fund Lp | Option Ex | 2,645,442 | .00 | 0 |
| 2016-11-16 | Langer Dennis (Director) | Sale | 23,766 | 3.52 | 83,656 |
| 2016-11-15 | Fambrough Douglas (Chief Executive Officer) | Buy | 16,500 | 3.63 | 59,895 |
| 2016-11-14 | Fambrough Douglas (Chief Executive Officer) | Buy | 16,600 | 3.78 | 62,748 |
| 2016-05-12 | Weissman James B (Chief Business Officer) | Buy | 5,000 | 3.27 | 16,365 |
| 2016-02-03 | Langer Dennis (Director) | Option Ex | 34,722 | 3.42 | 118,749 |
| 2015-02-20 | Kaneko Yasunori (Other) | Sale | 37,532 | 26.02 | 976,582 |
| 2014-12-17 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 2,500 | 3.42 | 8,550 |
| 2014-11-25 | Deerfield Private Design International Ii, L.p. | Sale | 121,965 | 11.50 | 1,402,597 |
| 2014-11-24 | Deerfield Private Design International Ii, L.p. | Sale | 100,000 | 11.54 | 1,154,500 |
| 2014-11-21 | Deerfield Private Design International Ii, L.p. | Sale | 100,000 | 11.00 | 1,100,000 |
| 2014-11-07 | Deerfield Private Design International Ii, L.p. | Sale | 214,164 | 9.20 | 1,970,308 |
| 2014-10-15 | Deerfield Private Design International Ii, L.p. | Sale | 51,449 | 10.01 | 515,004 |
| 2014-10-14 | Deerfield Private Design International Ii, L.p. | Sale | 36,115 | 11.02 | 397,987 |
| 2014-10-10 | Deerfield Private Design International Ii, L.p. | Sale | 30,214 | 12.07 | 364,622 |
| 2014-03-18 | Brookside Capital Trading Fund, L.p. (10% Owner) | Sale | 264,937 | 38.19 | 10,116,619 |
| 2014-03-17 | Brookside Capital Trading Fund, L.p. (10% Owner) | Sale | 9,301 | 36.50 | 339,486 |
| 2014-03-14 | Brookside Capital Trading Fund, L.p. (10% Owner) | Sale | 250,400 | 35.41 | 8,867,916 |
| 2014-03-12 | Brookside Capital Trading Fund, L.p. (10% Owner) | Sale | 1,500 | 37.77 | 56,655 |
| 2014-03-11 | Brookside Capital Trading Fund, L.p. (10% Owner) | Sale | 260,000 | 38.19 | 9,928,100 |
| 2014-02-04 | Deerfield Private Design International Ii, Ltd. | Buy | 1,000,000 | 15.00 | 15,000,000 |
| 2014-02-04 | Ra Capital Healthcare Fund Lp | Buy | 1,000,000 | 15.00 | 15,000,000 |
| 2014-02-04 | Kaneko Yasunori (10% Owner) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2014-02-04 | Hoffman Stephen J (Director) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2014-01-29 | Weissman James B (Chief Business Officer) | Buy | 1,000 | 15.00 | 15,000 |
| 2014-01-29 | Fambrough Douglas (Chief Executive Officer) | Buy | 5,000 | 15.00 | 75,000 |
| 2014-01-29 | Madden David (Director) | Buy | 7,500 | 15.00 | 112,500 |
| 2014-01-27 | Weissman James B (Chief Business Officer) | Option Ex | 11,283 | 3.24 | 36,556 |
| 2014-01-24 | Madden David (Director) | Option Ex | 112,511 | 3.42 | 384,787 |
| 2013-11-11 | Fambrough Douglas (Chief Executive Officer) | Option Ex | 9,300 | 3.42 | 31,806 |
| 2013-11-05 | Weissman James B (Chief Business Officer) | Option Ex | 833 | 3.42 | 2,848 |
Insider trading activities including stock purchases, stock sales, and option exercises of DRNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dicerna Pharmaceuticals Inc (symbol DRNA, CIK number 1399529) see the Securities and Exchange Commission (SEC) website.